Key statistics
As of last trade, Bavarian Nordic A/S (BAVA:CPH) traded at 210.70, 58.78% above the 52 week low of 132.70 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 214.40 |
---|---|
High | 215.00 |
Low | 210.60 |
Bid | 210.50 |
Offer | 210.80 |
Previous close | 214.70 |
Average volume | 300.70k |
---|---|
Shares outstanding | 78.83m |
Free float | 78.83m |
P/E (TTM) | 23.70 |
Market cap | 16.93bn DKK |
EPS (TTM) | 9.06 DKK |
Data delayed at least 15 minutes, as of Nov 01 2024 11:17 BST.
More ▼
- De første børn er vaccineret i nyt klinisk forsøg, der sigter mod at udvide indikationen for Bavarian Nordics mpox-vaccine
- First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine
- Bavarian Nordic indgår aftale med UNICEF om levering af 1 million doser mpox-vaccine
- Bavarian Nordic opjusterer sine økonomiske forventninger til 2024
- Bavarian Nordic Upgrades its Financial Guidance for 2024
- Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
- Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
- Bavarian Nordic modtager USD 63 mio. fra den amerikanske regering for produktion og levering af yderligere koppe- og mpoxvacciner
- Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
- Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
More ▼